Human ribonucleotide reductase. Activation and inhibition by analogs of ATP.

Sixteen ATP analogs were studied as activators of CDP reduction catalyzed by human ribonucleotide reductase. Activation constants were determined. Three analogs, 3-deazaATP, 5'-adenylimidodiphosphate, and 3'-dATP, activated approximately as efficiently as ATP. Four analogs were partial activators. These seven activators were also accessory activators of GDP reduction. Furthermore, two other analogs, adenosine-5'-O-(1-thiotriphosphate) and 8-bromoATP, selectively stimulated GDP reduction. Ten analogs, at equal molar concentrations with ATP, inhibited ATP-dependent activation of CDP reduction and/or accessory activation of GDP reduction by greater than 45%. No analog inhibited as potently as 2'-dATP, which had an IC50 of 30-50 microM versus the stimulation of CDP and GDP reduction by 2.0 mM ATP.

[1]  A. Cornish-Bowden,et al.  Concentration of MgATP2- and other ions in solution. Calculation of the true concentrations of species present in mixtures of associating ions. , 1976, The Biochemical journal.

[2]  A. Holmgren,et al.  Regulation of ribonucleotide reductase. , 1981, Current topics in cellular regulation.

[3]  T. Spector,et al.  A simple method to purify ribonucleotide reductase. , 1983, Analytical biochemistry.

[4]  C. Chang,et al.  Effects of nucleoside triphosphates on human ribonucleotide reductase from Molt-4F cells. , 1979, Cancer research.

[5]  T. Spector.  Improvement of a simple method to purify ribonucleotide reductase. , 1985, Preparative biochemistry.

[6]  C. Chang,et al.  Effects of deoxyadenosine triphosphate and 9-beta-D-arabinofuranosyl-adenine 5'-triphosphate on human ribonucleotide reductase from Molt-4F cells and the concept of "self-potentiation". , 1980, Cancer research.

[7]  S. Hopper.  [31] Ribonucleotide reductase of rabbit bone marrow , 1978 .

[8]  T. Spector,et al.  Effector studies of 3'-azidothymidine nucleotides with human ribonucleotide reductase. , 1987, Biochemical pharmacology.

[9]  R. Kucera,et al.  Studies on ribonucleoside-diphosphate reductase in permeable animal cells. II. Catalytic and regulatory properties of the enzyme in mouse L cells. , 1982, Archives of biochemistry and biophysics.

[10]  T. Spector,et al.  Ribonucleotide reductase induced by herpes simplex type 1 virus. Characterization of a distinct enzyme. , 1983, The Journal of biological chemistry.

[11]  S. Cha,et al.  Kinetics of enzyme reactions with competing alternative substrates. , 1968, Molecular pharmacology.

[12]  J. G. Cory,et al.  Protein properties of the subunits of ribonucleotide reductase and the specificity of the allosteric site(s). , 1986, Advances in enzyme regulation.

[13]  P. Reichard,et al.  Reduction of ribonucleotides. , 1979, Annual review of biochemistry.

[14]  W. Cleland,et al.  The statistical analysis of enzyme kinetic data. , 1967, Advances in enzymology and related areas of molecular biology.

[15]  T. Spector,et al.  Herpes simplex virus type 1 ribonucleotide reductase: selective and synergistic inactivation by A1110U and its iron complex. , 1990, Biochemical pharmacology.

[16]  C. Mathews,et al.  Vaccinia virus-induced ribonucleotide reductase can be distinguished from host cell activity , 1984, Journal of virology.

[17]  Y. Cheng,et al.  Nature and properties of mammalian ribonucleoside diphosphate reductase. , 1984, Pharmacology & therapeutics.

[18]  D. Hunting,et al.  Models of the regulation of ribonucleotide reductase and their evaluation in intact mammalian cells. , 1982, CRC critical reviews in biochemistry.

[19]  L Thelander,et al.  Allosteric regulation of calf thymus ribonucleoside diphosphate reductase. , 1979, Biochemistry.

[20]  S. Cohen,et al.  Effects of arabinonucleotides on ribonucleotide reduction by an enzyme system from rat tumor. , 1967, The Journal of biological chemistry.